Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

KARACHI: While final lab tests for confirmation of an active TB infection in two Safari Park elephants are yet to be ...

Discover powerful fruits and vegetables that may help Black women navigate breast cancer treatment more comfortably while ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...

The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...

Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...

Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...

After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the ...

Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute ...